CNMD STOCK?

Quote






anonymous said:
Who was a better CEO, Hartman or Corosanti?
Click to expand...
I think they are very different. Corasanti (the dad) was an entrepreneur. To that point he treated the business like everyone should be that way. The son tried the same approach. General managers had a lot of autonomy and ran businesses as they saw best. But the business changed: contracts become critical, bundling was happening with competitors more effectively and we started to lose market share. Then after too many failed/ weak product launches and lost business it was clear a change Was needed. Curt Knows what a better organization should look like and wants for everyone to be successful but he is too weak and dependent on a new management team to effect real change. His arrogance also frequently clouds judgement. I think this was suppose to be a swan song on his career where he thought he could just put on some quick band aids and have a quick turn around, then get a nice pay day with some m and a, then ride off into the sunset. Just my two cents... Only worth two cents.
 






Curt also thought that because he and his cronnies worked for Stryker that they know better than the Conmed team. Maybe now, maybe not, he realizes that this isn't Stryker, and doing it the Stryker way means little here. Curt is getting killed by the same companies Joe Corasanti was getting killed by, every quarter dying the same slow death. He has done nothing to prevent the same large companies from taking share every quarter that he's been here.
 






Oh come on now, Curt is a great Marketer. He's the one that came up with they saying, "this is Our Conmed", at the NSM earlier this year. I mean before Curt came along, it was "One Conmed". Don't ask me what "Our Conmed" or "One Conmed", mean. Curt certainly couldn't explain what Our Conmed means. It was amazing. How many of his stupid speeches did we have to sit thru? Absolutely nothing of any substance behind anything that guy says. All he talked about was "One Conmed", and "we are, and will be, a growth company". Nothing about any new products or programs. Everyone realizes the company was on the downswing when Curt came on, but now it's two years later and look at how much worse off we are.
 






I'm no fan of CT, but the blame for ConMed becoming an absolute commercial failure in the US is 100% JD's fault. That dude caused more damage, in less time, than any exec I've ever seen. A lot of us were hopeful when CT got rid of JD. But rebuilding US sales force and product roadmap has been a nightmare.

Best thing would have been for the board to sell the entire company when Corsanti left. But the product lines are now too old and fragmented. We don't even design and make half of the $hit we sell. And every possible buyer knows exactly how Fked up the company is behind the scenes. They could fire everyone above Director-level and no one would notice. Who wants to inherit that kind of baggage? It's been a good ride but it's time to move on.
 






but joe darling was not a ceo and I don't even think he was in his role more than 2 years? How could he have done more damage the Hartman who has been in the front office more than two years? He also made surgiquest purchase and they are hanging their hat on it now... That is going to sting later on.
 






anonymous said:
but joe darling was not a ceo and I don't even think he was in his role more than 2 years? How could he have done more damage the Hartman who has been in the front office more than two years? He also made surgiquest purchase and they are hanging their hat on it now... That is going to sting later on.
Click to expand...

At various times JD ran the Linvatec division and headed all of ConMed's sales and marketing. He was there for more than two years but it felt like decades. He had almost absolute autonomy. It's ancient history but remember that Corsanti was a very hands off CEO. He had a board filled with his father's cronies and spent most of the time in Naples enjoying life, making sure his family had well paying jobs, and allowing other people to manage the day to day.

CT made the Surgiquest purchase because he knew Stryker wanted it too. So it must be the right thing to acquire, right? They paid too much for the company but they've got a good product that costs too much. Stryker would throw a ton of resources at it to value engineer half the cost away. ConMed doesn't have the resources nor the scale to reduce the costs much. This may get hung on CT's neck when it fails but there were others that approved of that deal, starting with finance.
 












Atrocious Spark said:
The orthopedic engine that used to carry the company continues to lose market share. No new products and the lack of guidance from the AC team will spell the end for this company.
Click to expand...

Q4 looks to be another disaster. sports medicine will continue its freefall, visualization will be lucky to remain an active product line, and general surgery will only look good YOY due to the Surgiquest revenue that didn't exist in Q42015. CT has to be looking at making changes but nothing will change before mid-2017. What a nightmare.
 












anonymous said:
Here we go again with CNMD stock. Up - down , up - down, going up again. Can anyone make sense of this?
Click to expand...
This makes no sense to me. There are only ten orthopedic agents showing growth for the 3rd quarter and their total sales are very low. For example I don't think Endomed will break $700,000 in total sales for 2017. Alaska is up, but they are only going to deliver around $300,000 in sales for the year. Perhaps there is a price to unload part or the entire company. We know Ross Beam won't be cashing in.
 






Atrocious Spark said:
This makes no sense to me. There are only ten orthopedic agents showing growth for the 3rd quarter and their total sales are very low. For example I don't think Endomed will break $700,000 in total sales for 2017. Alaska is up, but they are only going to deliver around $300,000 in sales for the year. Perhaps there is a price to unload part or the entire company. We know Ross Beam won't be cashing in.
Click to expand...

Who's up in Ortho?
 


















I cannot understand why this company is still here? They have been shedding costs for years at the cost of growth. I thought surgiquest would be the nail in the coffin but the market bought the scam. It is to bad shareholders don't see the short term gains are at the cost of long term viability.
Oh and peters and Hartman are by far the worst people I have ever done business with, is it bad to say I hope they chock on their vomit and die?
 






It makes me cringe thinking about sitting thru more of Hartman's bullshit speeches in January at the orthopedic national sales meeting. What could he even possibly have to say to the sales force at this point? Think of how far downhill this company has gone in the last 2-years since he took over. I don't know if he just doesn't understand this business, doesn't care, or just doesn't have the budget to do anything. The only thing I know for sure is he received $7 million in compensation from Conmed in 2015.
 












Hartman and his band of merry men are all ASSHOLES. I hope they feel good about all the people and their families they have put out of work since they have formed their Brotherhood. They all make out while many suffer. Eventually good wins against evil...
 


















Top Bottom
Back
Quote